Home > Press > ISE-CCM Nanotechnology Index- Benchmark Index for the Nanotechnology Industry
Cronus Capital Markets and the International Securities Exchange jointly developed the index, which has options currently trading on the ISE (ISE:TNY). The ISE-CCM Nanotechnology Index includes top Nanotechnology companies such as Cabot Corp. (NYSE: CBT), Headwaters Inc. (NYSE: HW), Symyx Technologies Inc. (NASDAQ: SMMX), and FEI COMPANY
ISE-CCM Nanotechnology Index- Benchmark Index for the Nanotechnology Industry
New York, NY | Posted on May 7th, 2007
Cronus Capital Markets CEO Michael Soni remarked that 'the ISE-CCM Nanotechnology Index tracks the growth of this new and important sector. Michael Soni, CCM's President and CEO, stated that the ISE-CCM Nanotechnology Index is a necessary development for the still nascent sector. 'Investors will have a direct avenue in which to track and participate in the growth of this new and important sector.- Mr. Soni said.
ISE, the world's largest equity options exchange, was founded on the principle that technology fosters and infuses new efficiencies and operational innovations into securities trading. After developing an innovative market structure that integrated auction market principles into an advanced screen-based trading system, ISE launched the first fully electronic US options exchange in May 2000. ISE continually enhances its trading systems to provide investors with the best marketplace to execute their options orders. ( http://www.iseoptions.com )
About Cronus Capital Markets
Cronus Capital Markets (CCM) is a leading business consulting firm specializing on capital market related issues and how they impact small and mid-sized public companies. CCM work's with public companies in the United States and Canada interested to optimize their 'public company- status by offering solutions that unlock hidden value and lead to accelerated business growth. The primary mission of Cronus Capital Markets is to assist small and mid-sized public companies, in a wide variety of industries and emerging growth sectors, overcome market inefficiencies that are commonplace among public companies under $500 million in market capitalization, such as poor corporate awareness, stagnant market capitalization, low liquidity and poor access to funding.
For more information, please click here
Copyright © Cronus Capital Markets
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Dr. Ben J. Lipps designated as Chairman of the Management Board and Chief Executive Officer of Nanostart-holding MagForce AG June 17th, 2013
Harris & Harris Group Notes Carl Zeiss' Planned Acquisition of Xradia June 13th, 2013
Long Island Capital Alliance Announces Participants for Biotech Technology Transfer Capital Forum: Event to Be Held on June 14 in Collaboration With Cold Spring Harbor Laboratory June 8th, 2013
Iran to Hold Int'l Forum on Nanotechnology Economy (IFNE2013) May 30th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013